Establishment Labs Holdings Inc (ESTA) - Total Liabilities
Based on the latest financial reports, Establishment Labs Holdings Inc (ESTA) has total liabilities worth $336.25 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Establishment Labs Holdings Inc - Total Liabilities Trend (2016–2025)
This chart illustrates how Establishment Labs Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Establishment Labs Holdings Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Establishment Labs Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Establishment Labs Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dlocal Ltd
NASDAQ:DLO
|
USA | $971.53 Million |
|
Northwest Bancshares Inc
NASDAQ:NWBI
|
USA | $15.00 Billion |
|
Orbia Advance Corporation S.A.B. de C.V
F:4FZ
|
Germany | €8.43 Billion |
|
GCS Holdings
TWO:4991
|
Taiwan | NT$521.28 Million |
|
Turpaz Industries Ltd
TA:TRPZ
|
Israel | ILA347.32 Million |
|
Guangdong Ellington Electronics Technology Co Ltd
SHG:603328
|
China | CN¥2.33 Billion |
|
Yunnan Botanee Bio-Technology Group Co Ltd
SHE:300957
|
China | CN¥2.05 Billion |
|
Jenoptik AG
F:JEN
|
Germany | €679.42 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Establishment Labs Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Establishment Labs Holdings Inc worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 22.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.96 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Establishment Labs Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Establishment Labs Holdings Inc (2016–2025)
The table below shows the annual total liabilities of Establishment Labs Holdings Inc from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $333.62 Million | +13.58% |
| 2024-12-31 | $293.74 Million | +17.38% |
| 2023-12-31 | $250.25 Million | +14.14% |
| 2022-12-31 | $219.25 Million | +146.93% |
| 2021-12-31 | $88.79 Million | +9.04% |
| 2020-12-31 | $81.43 Million | +5.86% |
| 2019-12-31 | $76.92 Million | +63.35% |
| 2018-12-31 | $47.09 Million | -24.18% |
| 2017-12-31 | $62.11 Million | +10.91% |
| 2016-12-31 | $56.00 Million | -- |
About Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products… Read more